SAREPTA THERAPEUTICS, INC. Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
SAREPTA THERAPEUTICS, INC. (SRPT) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $249.24 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2018-08-08
- 2018-06-30: Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month $249.24M.
- 2017-06-30: Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month $163.52M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month |
|---|---|
| 2018-06-30 | $249.24M 10-Q · filed 2018-08-08 |
| 2017-06-30 | $163.52M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |